You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三葉草生物-B(02197.HK)與Gavi簽署預購協議修訂本
阿思達克 09-15 16:39
三葉草生物-B(02197.HK)公布,在2022年9月15日,公司與Gavi簽署在2021年6月與訂立一份預購協議的修訂本,並同意剔除預購協議所載之向中國市場供應疫苗劑的限制及剔除Gavi針對原先的選擇性劑量在各COVAX獲取新冠病毒工具加速計劃的疫苗支柱, 此外,公司與Gavi同意在四年的延長期限內,將先前的承諾訂單轉換為6,400萬劑SCB-2019的選擇權,並剔除最初的最多3.5億劑選擇購買權。至今,公司已收到Gavi支付的2.24億美元,作為購買最初6,400萬劑訂單所需的不可退回材料的預付款。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account